SCHEMBL4597554

SCHEMBL4597554

Cc1oncc1C(=O)N1CCC[C@H](c2nc(-c3ccc(F)cc3F)no2)C1.O=C(c1ccc(F)nc1)N1CCC[C@H](c2nc(-c3ccccc3F)no2)C1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
LMNA P02545 2/20 0.55
TSHR P16473 2/20 0.55
HTT P42858 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
NPSR1 Q6W5P4 2/20 0.51
HSD11B1 P28845 4/20 0.51
GRM5 P41594 1/20 0.50
CLPP Q16740 1/20 0.50
RAB9A P51151 1/20 0.50
POLB P06746 1/20 0.49
TP53 P04637 1/20 0.48
ALOX15 P16050 1/20 0.48
MAPK1 P28482 1/20 0.48
ATM Q13315 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
BTK Q06187 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4598435 0.94 ALDH1A1 (0.56) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL4130445 0.90 ALDH1A1 (0.66) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL4130449 0.90 ALDH1A1 (0.66) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL4138624 0.89 GRM5 (0.62) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL4138615 0.89 GRM5 (0.62) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL4151267 0.88 HSD11B1 (0.63) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL4151273 0.88 HSD11B1 (0.63) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL4147615 0.86 GRM5 (0.60) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL4147608 0.86 GRM5 (0.60) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL4136224 0.82 ALDH1A1 (0.68) ALDH1A1LMNATSHRHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896463-A2 NOVEL OXADIAZOLE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX Pharma S.A. (CH) 2008-03-12 EP disclosed
WO-2006123249-A2 NOVEL OXADIAZOLE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA SA (CH) 2006-11-23 WO disclosed